Dow Jumps 300 Points; Gap Posts Upbeat Earnings

BenzingaNov 22 10:23 ET

Aptose Biosciences Brief: Pricing US$8 Million Public Offering

MT NewswiresNov 22 08:00 ET

Aptose Biosciences Inc. Announces Pricing of $8 Million Public Offering

GlobeNewswireNov 22 08:00 ET

Why Elastic Shares Are Trading Higher By 29%; Here Are 20 Stocks Moving Premarket

BenzingaNov 22 05:29 ET

Aptose Biosciences Is Maintained at Buy by HC Wainwright & Co.

Dow JonesNov 20 13:11 ET · Ratings

Aptose Biosciences Analyst Ratings

BenzingaNov 20 12:59 ET · Ratings